SGMO - Sangamo Therapeutics Inc. (SGMO) CEO Sandy Macrae on Q4 2020 Results - Earnings Call Transcript
Sangamo Therapeutics, Inc. (SGMO) Q4 2020 Earnings Conference Call February 24, 2021 5:00 PM ET Company Participants Aron Feingold - Head of Corporate Communications Sandy Macrae - Chief Executive Officer Bettina Cockroft - Senior Vice President and Chief Medical Officer Jason Fontenot - Senior Vice President, Chief Scientific Officer Mark McClung - Executive Vice President and Chief Business Officer Rob Schott - Senior Vice President and Head of Development. Conference Call Participants Maurice Raycroft - Jefferies Geoff Meacham - Bank of America Gena Wang - Barclays Ritu Baral - Cowen Ben Burnett - Stifel Andreas Argyrides - Wedbush Securities Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to Sangamo Fourth Quarter and Full Year 2020 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Aron Feingold, Head of Corporate
For further details see:
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q4 2020 Results - Earnings Call Transcript